Oritus Mini Syrup is a combination oral medication containing Chlorpheniramine Maleate 2mg and Phenylephrine 5mg per 5ml, formulated to provide symptomatic relief from allergic conditions and nasal congestion. Chlorpheniramine Maleate is a first-generation antihistamine that competitively inhibits H1 histamine receptors, thereby reducing symptoms such as sneezing, runny nose, and itching associated with allergic rhinitis, hay fever, and other hypersensitivity reactions. Phenylephrine acts as a selective alpha-1 adrenergic receptor agonist, producing vasoconstriction of nasal mucosal blood vessels, which leads to decreased nasal congestion and improved airway patency. Oritus Mini Syrup is indicated for the management of allergic rhinitis, common cold symptoms, and sinusitis in pediatric patients. The syrup formulation allows for ease of administration and accurate dosing in children. It is important to adhere to the recommended dosage and duration of therapy to minimize potential side effects such as drowsiness, dry mouth, or increased blood pressure. Use with caution in patients with hypertension, cardiovascular disease, or hyperthyroidism. Oritus Mini Syrup should be used under medical supervision, and patients should be advised to avoid concomitant use with other sympathomimetic or antihistaminic agents unless directed by a healthcare professional.